Retroperitoneal Packing or Angioembolization for Hemorrhage Control of Pelvic Fractures
1 other identifier
interventional
56
1 country
1
Brief Summary
This study is designed to answer whether minimal invasive vessel clotting (angioembolization) or open surgery (retroperitoneal packing) is more effective for pelvic fractures with massive bleeding. Patients admitted at daytime (7am-5pm) are treated with angioembolization while patients admitted at nighttime (5pm to 7am) are treated with open surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2003
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2003
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2013
CompletedFirst Submitted
Initial submission to the registry
August 5, 2015
CompletedFirst Posted
Study publicly available on registry
August 28, 2015
CompletedOctober 30, 2017
October 1, 2017
10 years
August 5, 2015
October 27, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Number of participants deceased occurring in-hospital during or after treatment with packing or embolization
participants will be followed for the duration of hospital stay, an expected average of 6 weeks
Secondary Outcomes (6)
Number of Participants with Adverse Events as a Measure of Safety and Tolerability
participants will be followed for the duration of hospital stay, an expected average of 6 weeks
Number of postoperative packed red blood cell units administered for each participant
participants will be followed for the duration of hospital stay, an expected average of 6 weeks
Number of participants which required a secondary procedure (PACKING or ANGIO) after the primary intervention (PACKING or ANGIO)
participants will be followed for the duration of hospital stay, an expected average of 6 weeks
Time from admission (in minutes) to treatment (PACKING or ANGIO) for each participant
participants will be followed for the duration of hospital stay, an expected average of 6 weeks
Procedural/surgical time (in minutes) for each participant
participants will be followed for the duration of hospital stay, an expected average of 6 weeks
- +1 more secondary outcomes
Study Arms (2)
ANGIO
ACTIVE COMPARATORPatients with persistent hemodynamic instability (systolic blood pressure (SBP) \<90 mmHg after the transfusion of 4 packed red blood cell (PRBC) units in the emergency department) were taken urgently to the angiography suite for pelvic angiography. These patients had to tolerate transfer to the suite. Patients receiving primarily angioembolization therapy were defined as the ANGIO group.
PACKING
ACTIVE COMPARATORIndication for pelvic packing was persistent SBP\<90 mmHg during the initial resuscitation period with 3000 ml of intravenous (IV) crystalloids and transfusion of 4 PRBC units. These patients were treated primarly with retroperitoneal packing, while angioembolization OR staff was unavailable (5pm-7am), and were defined as the PACK group.
Interventions
By retroperitoneal access the space in front of the pelvic fracture is compressed with surgical towels, which stops effectively venous bleeding
Using en endovascular approach, bleeding arteries are identified and clotted using embolizing agents, or coils.
Eligibility Criteria
You may qualify if:
- multitrauma defined as Injury Severity Score (ISS) \> 17
- dislocated pelvic fracture type B or C according to Tile\[10\] on emergency department pelvic radiograph
- hemodynamic instability defined as systolic blood pressure (SBP) \<90 mmHg after administration of 4 units of packed red blood cells (PRBC).
You may not qualify if:
- monotrauma, or ISS ≤ 17
- age \> 65 years
- age \< 18 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Uppsala Universitylead
- Shandong Provincial Hospitalcollaborator
Study Sites (1)
Shandong Provincial Hospital
Jinan, Shandong, 250021, China
Related Publications (1)
Li Q, Dong J, Yang Y, Wang G, Wang Y, Liu P, Robinson Y, Zhou D. Retroperitoneal packing or angioembolization for haemorrhage control of pelvic fractures--Quasi-randomized clinical trial of 56 haemodynamically unstable patients with Injury Severity Score >/=33. Injury. 2016 Feb;47(2):395-401. doi: 10.1016/j.injury.2015.10.008. Epub 2015 Oct 22.
PMID: 26508436DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Dongsheng Zhou, MD, PhD
Shandong Provincial Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 5, 2015
First Posted
August 28, 2015
Study Start
February 1, 2003
Primary Completion
February 1, 2013
Study Completion
February 1, 2013
Last Updated
October 30, 2017
Record last verified: 2017-10